Lili Belcastro

Lili Belcastro, PhD is an Associate Director in Cell Therapy Development at Bristol Myers Squibb, leading the early development raw materials team and serving as a subject matter expert in cell and gene therapy ancillary materials, single-use systems, and starting materials. With more than 15 years of experience in cancer biology, biologics, and advanced therapies, she specializes in raw material strategy for scalable CGT manufacturing. Dr. Belcastro is Chair of the USP Bio4 Cell and Gene Therapies Expert Committee, contributes to multiple industry standards organizations, teaches regulatory science at Saint Joseph’s University, and regularly publishes and presents on CGT raw materials.